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COMPLEX NEW MODALITIES REQUIRE ADVANCED BIOMANUFACTURING PLATFORMS:  THE CASE 
OF EXOSOME BIOTHERAPEUTICS 
 




Exosome-based therapeutics are rapidly evolving as a high potential new modality in multiple clinical areas such 
as oncology, immuno oncology, neurology and tissue regeneration, among others.  As these indications involve 
large patient populations, the implementation of exosome therapeutics requires robust manufacturing processes 
yielding large quantities of highly purified material.  However, the complexity and heterogeneity of exosomes 
pose significant R&D challenges.  Here, we present the successful development of a large-scale manufacturing 
process using engineered human cells grown in a high-density continuous culture.  The upstream process is 
followed by a sequence of purification steps yielding material of high purity and quality.  The related analytical 
and characterization methods are also discussed. 
 
 
